Alhazzani, K.; Almangour, A.; Alsalem, A.; Alqinyah, M.; Alhamed, A.S.; Alhamami, H.N.; Alanazi, A.Z.
Examining the Effects of Dasatinib, Sorafenib, and Nilotinib on Vascular Smooth Muscle Cells: Insights into Proliferation, Migration, and Gene Expression Dynamics. Diseases 2023, 11, 147.
https://doi.org/10.3390/diseases11040147
AMA Style
Alhazzani K, Almangour A, Alsalem A, Alqinyah M, Alhamed AS, Alhamami HN, Alanazi AZ.
Examining the Effects of Dasatinib, Sorafenib, and Nilotinib on Vascular Smooth Muscle Cells: Insights into Proliferation, Migration, and Gene Expression Dynamics. Diseases. 2023; 11(4):147.
https://doi.org/10.3390/diseases11040147
Chicago/Turabian Style
Alhazzani, Khalid, Abdullah Almangour, Abdulaziz Alsalem, Mohammed Alqinyah, Abdullah S. Alhamed, Hussain N. Alhamami, and Ahmed Z. Alanazi.
2023. "Examining the Effects of Dasatinib, Sorafenib, and Nilotinib on Vascular Smooth Muscle Cells: Insights into Proliferation, Migration, and Gene Expression Dynamics" Diseases 11, no. 4: 147.
https://doi.org/10.3390/diseases11040147
APA Style
Alhazzani, K., Almangour, A., Alsalem, A., Alqinyah, M., Alhamed, A. S., Alhamami, H. N., & Alanazi, A. Z.
(2023). Examining the Effects of Dasatinib, Sorafenib, and Nilotinib on Vascular Smooth Muscle Cells: Insights into Proliferation, Migration, and Gene Expression Dynamics. Diseases, 11(4), 147.
https://doi.org/10.3390/diseases11040147
